Researchers employ ARA-290 to investigate its selective binding to the innate repair receptor (IRR = EPOR-β common receptor complex), resulting in anti-apoptotic and anti-inflammatory responses independent of red blood cell production. Pre-clinical observations in neuropathic and inflammatory models indicate reduced cytokine expression (TNF-α, IL-6), preservation of neuronal function, and attenuation of pain-related signaling.
This EPO-derived peptide facilitates examination of receptor-mediated protective cascades, modulation of inflammatory pathways, and tissue resilience in stress or injury research paradigms.
Scientific Overview of ARA-290 Applications
Pre-clinical models demonstrate ARA-290’s engagement with tissue-protective mechanisms:
- Selective activation of the innate repair receptor (IRR), promoting anti-apoptotic signaling and cellular survival without hematopoietic effects in neuronal and peripheral tissue models.
- Reduction of pro-inflammatory cytokine production (TNF-α, IL-6) and attenuation of inflammatory responses in neuropathy and sarcoidosis-related systems.
- Support for neuronal integrity and functional recovery in models of small-fiber neuropathy and metabolic stress.
- Modulation of pain signaling pathways and corneal nerve fiber density in diabetic neuropathy research contexts.
- Examination of cytoprotective effects in ischemia-reperfusion and chronic inflammatory paradigms.
- Investigation of IRR-mediated responses in models of tissue repair and neuroinflammation.
For further details on EPO-derived peptides, innate repair receptor signaling, and tissue-protective mechanisms in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Why Investigators Select National Science Labs ARA-290
National Science Labs manufactures ARA-290 under rigorous GMP-compliant protocols to ensure batch-to-batch consistency and reliability for pre-clinical experiments. Independent third-party testing verifies each lot for:
- Purity ≥99.9% by HPLC
- Structural identity confirmation via mass spectrometry
- Complete Certificate of Analysis (CoA) documentation provided per batch
For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements about this peptide have not been evaluated by the FDA.
Initiate Your ARA-290 Research Protocol
Source high-purity ARA-290 from current limited batches to ensure optimal stability and performance in tissue-protective and neuropathic signaling studies.
